Physician profile
Aaron Farrow
NPI 1376864439
$172,160.73
in general payments reported to CMS, 2019-2025
80 companies · $47K in 2025
The $47K reported for 2025 was more than what 96% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $16K · 2021: $17K · 2022: $24K · 2023: $15K · 2024: $29K · 2025: $47K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $73K · Food and Beverage: $14K · Consulting Fee: $2,462 · Travel and Lodging: $1,139 · Education: $71.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $72,844.00 |
| Food and Beverage | $14,353.16 |
| Consulting Fee | $2,462.00 |
| Travel and Lodging | $1,139.40 |
| Education | $71.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $116,566.44 | 2019-2025 | Vumerity, Tysabri, Tysabri |
| Abbvie INC. | $30,546.48 | 2021-2025 | |
| Ucb, INC. | $1,965.85 | 2019-2025 | Briviact, Rystiggo, Zilbrysq |
| Novartis Pharmaceuticals Corporation | $1,550.63 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $1,322.09 | 2019-2025 | Ajovy, Austedo Xr, Austedo Xr |
| Lundbeck LLC | $1,222.06 | 2019-2025 | Vyepti, Rexulti |
| Allergan, INC. | $1,032.80 | 2019-2022 | |
| Amgen INC. | $1,030.48 | 2019-2025 | Uplizna, Aimovig |
| Acadia Pharmaceuticals INC | $968.14 | 2020-2025 | Nuplazid, Daybue |
| Alexion Pharmaceuticals, INC. | $915.76 | 2019-2025 | Ultomiris |
| Supernus Pharmaceuticals, INC. | $845.53 | 2019-2022 | |
| Genentech USA, INC. | $838.49 | 2019-2025 | Ocrevus, Ocrevus Zunovo |
| Genzyme Corporation | $831.63 | 2019-2023 | |
| Sk Life Science, INC. | $823.67 | 2020-2025 | Xcopri |
| Merz Pharmaceuticals, LLC | $803.89 | 2021-2025 | Xeomin, Inbrija |
Show all 80 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $797.37 | 2020-2025 | |
| Eisai INC. | $528.45 | 2020-2025 | |
| Impel Pharmaceuticals INC. | $505.42 | 2022-2023 | Trudhesa |
| Tg Therapeutics, INC. | $495.23 | 2023-2025 | |
| Lilly USA, LLC | $457.13 | 2019-2025 | Emgality, Reyvow, Kisunla |
| Alnylam Pharmaceuticals INC. | $423.86 | 2019-2024 | Onpattro |
| Amneal Pharmaceuticals LLC | $410.85 | 2019-2025 | Rytary, Ongentys, Crexont |
| Sunovion Pharmaceuticals INC. | $401.42 | 2019-2022 | |
| Livanova USA, INC. | $399.85 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Biohaven Pharmaceuticals, INC. | $350.46 | 2021 | |
| Upsher-Smith Laboratories LLC | $348.03 | 2019-2022 | |
| Neurocrine Biosciences, INC. | $344.85 | 2021-2025 | Ingrezza, Ongentys |
| Csl Behring | $342.27 | 2020-2025 | Hizentra |
| Biohaven Pharmaceutical Holding Company Ltd. | $337.43 | 2022 | |
| Celgene Corporation | $324.91 | 2020-2025 | Zeposia |
| Janssen Pharmaceuticals, INC | $309.72 | 2020-2023 | Ponvory |
| Emd Serono, INC. | $292.64 | 2019-2023 | Mavenclad |
| Kyowa Kirin, INC. | $273.15 | 2020-2024 | Nourianz |
| Argenx US, INC. | $271.83 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| E.R. Squibb & Sons, L.L.C. | $264.63 | 2020-2022 | |
| Mdd US Operations, LLC | $255.34 | 2019-2020 | |
| Grifols USA, LLC | $216.72 | 2019-2025 | Gamunex-C |
| Ge Healthcare | $188.79 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $179.44 | 2023-2024 | Aptiom |
| Acorda Therapeutics, INC | $168.93 | 2019-2023 | Ampyra, Inbrija |
| Vanda Pharmaceuticals INC. | $167.87 | 2024-2025 | Ponvory |
| Adamas Pharmaceuticals, INC. | $129.37 | 2019-2021 | |
| Horizon Therapeutics Plc | $122.57 | 2022 | |
| Jazz Pharmaceuticals INC. | $101.12 | 2021-2025 | |
| Mallinckrodt Enterprises LLC | $98.23 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $84.58 | 2022-2025 | Dysport |
| Catalyst Pharmaceuticals, INC. | $83.20 | 2023-2025 | Fycompa |
| Arbor Pharmaceuticals, INC. | $82.58 | 2019-2022 | |
| Avion Pharmaceuticals | $81.51 | 2022 | |
| Corium, LLC | $81.51 | 2022-2023 | Adlarity |
| Azurity Pharmaceuticals, INC. | $66.64 | 2023-2025 | Horizant, Horizant |
| Tanabe Pharma America, INC. | $62.03 | 2019-2022 | |
| Medtronic, INC. | $61.66 | 2022-2025 | Intellis Adaptivestim, Inceptiv |
| Greenwich Biosciences, INC. | $61.11 | 2019 | |
| Ani Pharmaceuticals, INC. | $56.82 | 2022-2023 | Purified Cortrophin Gel |
| Impel Pharmaceuticals LLC | $54.30 | 2025 | Trudhesa |
| Grt US Holding, INC. | $42.72 | 2022 | |
| Vertical Pharmaceuticals, LLC | $41.40 | 2019 | |
| Strongbridge US INC. | $39.62 | 2019-2020 | |
| Xeris Pharmaceuticals, INC. | $39.58 | 2021-2022 | |
| Octapharma USA, INC. | $39.37 | 2023 | Panzyga, Octagam Immune Globulin (Human) |
| Scilex Pharmaceuticals INC. | $36.56 | 2023 | Ztlido |
| Astrazeneca Pharmaceuticals Lp | $33.45 | 2025 | Wainua |
| Promius Pharma LLC | $33.42 | 2019 | |
| Mallinckrodt Hospital Products INC. | $30.63 | 2020 | |
| Avanir Pharmaceuticals, INC. | $29.38 | 2019-2022 | |
| Zogenix INC. | $27.30 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $24.92 | 2023 | Rexulti |
| Banner Life Sciences, LLC | $23.34 | 2023 | |
| Sandoz INC. | $23.12 | 2023 | |
| Dynasplint Systems INC. | $20.27 | 2025 | Dynasplint |
| Endo Pharmaceuticals INC. | $18.63 | 2020 | |
| Neurelis, INC. | $16.94 | 2023 | Valtoco |
| Tonix Medicines, INC. | $14.22 | 2025 | Zembrace Symtouch |
| Takeda Pharmaceuticals U.S.A., INC. | $13.57 | 2024 | Hyqvia |
| Collegium Pharmaceutical, INC. | $13.52 | 2022 | |
| Almatica Pharma LLC | $13.02 | 2021 | |
| Currax Pharmaceuticals LLC | $12.89 | 2023 | Onzetra Xsail |
| Zyla Life Sciences, INC. | $12.62 | 2020 | |
| Ultragenyx Pharmaceutical INC. | $12.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Farrow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.